概述

  • 产品名称Anti-TPD52L2抗体
    参阅全部 TPD52L2 一抗
  • 描述
    山羊多克隆抗体to TPD52L2
  • 特异性ab77337 is expected to recognise all reported isoforms (NP_955392.1; NP_955393.1; NP_955394.1; NP_955395.1; NP_003279.2; NP_955391.1).
  • 经测试应用适用于: WB, ELISAmore details
  • 种属反应性
    与反应: Human
    预测可用于: Cynomolgus Monkey, Orangutan
  • 免疫原

    Synthetic peptide:

    C-SGDKPLSDPAP

    , corresponding to C terminal amino acids 195-205 of Human TPD52L2 (NP_955392.1; NP_955393.1; NP_955394.1; NP_955395.1; NP_003279.2; NP_955391.1).

  • 阳性对照
    • Human Breast Cancer and human brain lysates.

性能

  • 形式Liquid
  • 存放说明Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
  • 存储溶液Preservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris buffered saline, pH 7.3
  • Concentration information loading...
  • 纯度Immunogen affinity purified
  • 纯化说明ab77337 was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • 克隆多克隆
  • 同种型IgG
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab77337 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB
ELISA
  • 应用说明ELISA: Use at an assay dependent dilution.
    Antibody detection limit dilution 1/16,000.

    WB: Use at a concentration of 0.1 - 0.3 µg/ml. Detects a band of approximately 28 kDa.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • 靶标

    Anti-TPD52L2 antibody 图像

    Anti-TPD52L2 antibody (ab77337)参考文献

    ab77337 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab77337.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"